LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 38 transactions totaling $1.8M, demonstrating a bullish sentiment with $1.8M in net insider flow. The most recent transaction on Oct 3, 2023 involved a purchase of 5,527 shares valued at $13.9K.
No significant insider buying has been recorded for LIXT in the recent period.
No significant insider selling has been recorded for LIXT in the recent period.
Based on recent SEC filings, insider sentiment for LIXT is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading LIXT stock, having executed 38 transactions in the past 90 days. The most active insider is Gil Schwartzberg (Executive), who has made 5 transactions totaling $560.3K.
Get notified when executives and directors at LIXT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | Bernards Rene | Executive | Purchase | 5,527 | $2.51 | $13.9K | |
| Oct 3, 2023 | Baan Bastiaan Jeroen Van Der | Executive | Purchase | 10,000 | $2.80 | $28.0K | |
| Oct 3, 2023 | Bernards Rene | Executive | Purchase | 5,527 | $2.51 | $13.9K | |
| Oct 2, 2023 | Bernards Rene | Executive | Purchase | 4,473 | $2.29 | $10.2K | |
| Oct 2, 2023 | Bernards Rene | Executive | Purchase | 4,473 | $2.29 | $10.2K | |
| Dec 30, 2022 | Baan Bastiaan Jeroen Van Der | Executive | Purchase | 10,000 | $4.90 | $49.0K | |
| Dec 30, 2022 | Baan Bastiaan Jeroen Van Der | Executive | Purchase | 10,000 | $0.49 | $4.9K | |
| Dec 15, 2022 | Bernards Rene | Executive | Purchase | 15,000 | $0.51 | $7.7K | |
| Dec 12, 2022 | Bernards Rene | Executive | Purchase | 10,000 | $0.61 | $6.1K | |
| Dec 9, 2022 | Forman Eric | Executive | Purchase | 10,000 | $0.60 | $6.0K | |
| Dec 9, 2022 | Forman Eric | Executive | Purchase | 5,000 | $0.63 | $3.1K | |
| Dec 9, 2022 | Forman Eric | Executive | Purchase | 1,112 | $0.63 | $701 | |
| Nov 22, 2022 | Forman Eric | Executive | Purchase | 2,484 | $0.56 | $1.4K | |
| Nov 21, 2022 | Brown Regina | Executive | Purchase | 2,600 | $0.58 | $1.5K | |
| Nov 21, 2022 | Brown Regina | Executive | Purchase | 2,400 | $0.57 | $1.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 29 | $1.8M | 94.6% |
Exercise(M) | 3 | $101.0K | 5.4% |
Payment(F) | 1 | $0 | 0.0% |
Gift(G) | 5 | $0 | 0.0% |
Insiders at LIXTE BIOTECHNOLOGY HOLDINGS, INC. are accumulating shares at an accelerated pace. With 11 insiders making 38 transactions totaling $1.8M in purchases versus $0 in sales, the net buying activity of $1.8M signals strong executive confidence. Gil Schwartzberg (Executive) leads the buying activity with $560.3K in transactions across all time.